Patent · US Expired

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin

US6019967A · kind A · utility

113Cited by
5References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 1996
Grant dateFeb 1, 2000
Priority date
Expiry dateJan 26, 2016

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Topically applicable pharmaceutical/dermatological/cosmetic compositions well suited for the therapeutic treatment or care of sensitive human skin, hair, mucous membranes, nails and/or the scalp, in particular for reducing or avoiding the skin-irritant side effects of a variety of bioactive agents, for example the .alpha.-hydroxy acids, comprise a therapeutically/cosmetically effective amount of at least one calcitonin gene related peptide ("CGRP") antagonist, e.g., CGRP 8-37 or an anti-CGRP antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.